SB
Supriya Baran Chanda
About Supriya Baran Chanda
Data last updated:
Supriya Baran Chanda is an Additional Director at Ardentlife Pharmaceutical Private Limited (since 2025). The companies operate in Pharma. Earlier, Supriya Baran Chanda was a Designated Partner at Subiix Pharmaceuticals Llp (2019–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 12 Aug 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 09 Jan 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Supriya Baran Chanda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Subhash Sopanrao Suryawanshi | 06922285 | Ardentlife Pharmaceutical Private Limited | Director |
| Vijay Singh Patel | 10696555 | Ardentlife Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supriya Baran Chanda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supriya Baran Chanda
Supriya Baran Chanda currently holds 1 directorship: Ardentlife Pharmaceutical Private Limited (Additional Director, since 12 Aug 2025).
Supriya Baran Chanda was first appointed on 09 Jan 2019 as Designated Partner at Subiix Pharmaceuticals Llp. The most recent appointment on record is 12 Aug 2025 at Ardentlife Pharmaceutical Private Limited.
Supriya Baran Chanda held 1 earlier board appointment: Subiix Pharmaceuticals Llp (Designated Partner, 09 Jan 2019 to 01 Aug 2020).
The current boards of Supriya Baran Chanda's companies include Subhash Sopanrao Suryawanshi (Ardentlife Pharmaceutical Private Limited), Vijay Singh Patel (Ardentlife Pharmaceutical Private Limited).